[Federal Register Volume 84, Number 97 (Monday, May 20, 2019)]
[Notices]
[Pages 22873-22874]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10445]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Notice of meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention's (CSAP) Drug Testing Advisory 
Board (DTAB) will convene via in person and web conference on June 11, 
2019, from 9:30 a.m. EDT to 4:30 p.m. EDT, and June 12, 2019, from 9:00 
a.m. EDT to 4:00 p.m. EDT.
    The Board will meet in open-session in-person on June 11, 2019, 
from 9:30 a.m. EDT to 4:30 p.m. EDT and on June 12, 2019, from 9:00 
a.m. EDT to 10:00 a.m. EDT to discuss the proposed Mandatory Guidelines 
for Federal Workplace Drug Testing Programs (urine specimens) with 
updates from the Department of Transportation, Nuclear Regulatory 
Commission, and the Departmetment of Defense. There will be additional 
presentations from the Division of Workplace Programs' staff on urine, 
oral fluid, hair Mandatory Guidelines, emerging issues surrounding 
marijuana legalization, and latest studies from the Behavioral 
Pharmacology Research Unit (BPRU). The board will meet in closed-
session in-person on June 12, 2019, from 10:00 a.m. EDT to 4:00 p.m. 
EDT to discuss confidential issues surrounding the

[[Page 22874]]

proposed Mandatory Guidelines for Federal Workplace Drug Testing 
Programs (urine specimens, oral fluid, hair), invalids, studies from 
Johns Hopkins BPRU, impact of cannabis laws on drug testing and future 
direction, potential recommendations to the Assistant Secretary for 
Mental Health and Substance Use regarding additional drugs that may be 
tested for in the future, and lastly, program financials. Therefore, 
June 12, 2019, from 10:00 a.m. EDT to 4:00 p.m. EDT meeting is closed 
to the public, as determined by the Assistant Secretary for Mental 
Health and Substance Use, SAMHSA, in accordance with 5 U.S.C. 
552b(c)(4) and (9)(B), and 5 U.S.C. App. 2, Section 10(d).
    Meeting registration information can be completed at http://snacregister.samhsa.gov/MeetingList.aspx. Web conference and call 
information will be sent after completing registration. Meeting 
information and a roster of DTAB members may be obtained by accessing 
the SAMHSA Advisory Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings or by contacting the Designated Federal 
Officer, Matthew Aumen.
    Committee Name: Substance Abuse and Mental Health Services 
Administration, Center for Substance Abuse Prevention, Drug Testing 
Advisory Board.
    Dates/Time/Type: June 11, 2019, from 9:30 a.m. to 4:30 p.m. EDT: 
OPEN, June 12, 2019, from 9:00 a.m. to 10:00 a.m. EDT: OPEN, June 12, 
2019, from 10:00 a.m. to 4:00 p.m. EDT: CLOSED.
    Place: Hilton Washington DC/Rockville Hotel & Executive Meeting 
Center, 1750 Rockville Pike, Rockville, MD 20852.
    Contact: Matthew Aumen, Program Analyst, Center for Substance Abuse 
Prevention, 5600 Fishers Lane, Room 16E61A, Rockville, Maryland 20857, 
Telephone: (240) 276-2419, Email: [email protected].

Charles LoDico,
Chemist.
[FR Doc. 2019-10445 Filed 5-17-19; 8:45 am]
 BILLING CODE 4162-20-P